UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 423

Sortiert nach

Digitizing clinical trials

NPJ digital medicine, 2020-07, Vol.3 (1), p.101-101, Article 101

2020

Volltextzugriff (PDF)

Phase I Trial of Bortezomib and Carboplatin in Recurrent Ovarian or Primary Peritoneal Cancer

Journal of clinical oncology, 2005-09, Vol.23 (25), p.5943-5949

2005

Volltextzugriff (PDF)

Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancer

Annals of oncology, 2016-04, Vol.27 Suppl 1 (suppl_1), p.i4-i10

2016

Volltextzugriff (PDF)

Management and outcomes for elderly women with vulvar cancer over time

BJOG : an international journal of obstetrics and gynaecology, 2014-05, Vol.121 (6), p.719-727

2014

Volltextzugriff (PDF)

A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852)

Annals of oncology, 2017-03, Vol.28 (3), p.505-511

2017

Volltextzugriff (PDF)

Reply to the letter to the editor ‘Integrating communication as a core skill in the global curriculum for medical oncology’ by Horlait et al

Annals of oncology, 2017-04, Vol.28 (4), p.905-906

2017

Volltextzugriff (PDF)

Retrospective Analysis of Carboplatin and Paclitaxel as Initial Second-Line Therapy for Recurrent Epithelial Ovarian Carcinoma: Application Toward a Dynamic Disease State Model of Ovarian Cancer

Journal of clinical oncology, 2002-03, Vol.20 (5), p.1238-1247

Dizon, D. S.

2002

Volltextzugriff (PDF)

Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva

Gynecologic oncology, 2012-10, Vol.127 (1), p.141-146

2012

Volltextzugriff (PDF)

A phase II trial of combination nivolumab and bevacizumab in recurrent ovarian cancer

Annals of oncology, 2018-10, Vol.29, p.viii334-viii335

2018

Volltextzugriff (PDF)

Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) study

Breast cancer research and treatment, 2021-08, Vol.189 (1), p.93-101

2021

Volltextzugriff (PDF)

Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of Müllerian origin

Gynecologic oncology, 2019-05, Vol.153 (2), p.223-229

2019

Volltextzugriff (PDF)

A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer

Gynecologic oncology, 2016-04, Vol.141 (1), p.108-112

2016

Volltextzugriff (PDF)

The factor V Leiden mutation may predispose women to severe preeclampsia

American journal of obstetrics and gynecology, 1996-10, Vol.175 (4), p.902-905

1996

Volltextzugriff (PDF)

Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction

American journal of obstetrics and gynecology, 1997-08, Vol.177 (2), p.402-405

1997

Volltextzugriff (PDF)

A Phase I Trial of the Novel Proteasome Inhibitor PS341 in Advanced Solid Tumor Malignancies

Clinical cancer research, 2002-08, Vol.8 (8), p.2505-2511

2002

Volltextzugriff (PDF)

The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis

American journal of obstetrics and gynecology, 1997-04, Vol.176 (4), p.883-886

1997

Volltextzugriff (PDF)

A promoter mutation that increases transcription of the tumor necrosis factor-α gene is not associated with preterm delivery

American journal of obstetrics and gynecology, 1997-10, Vol.177 (4), p.810-813

1997

Volltextzugriff (PDF)

Importance of clarifying patients' desired role in shared decision making to match their level of engagement with their preferences

BMJ (Online), 2013-12, Vol.347, p.f7066

2013

Volltextzugriff (PDF)

The sexuality clinic in the breast center: sex as a survivorship issue

Breast cancer online, 2008-12, Vol.11 (12), Article e23

2008

Volltextzugriff (PDF)

A promoter mutation in the tumor necrosis factor α gene is not associated with preeclampsia

Journal of reproductive immunology, 1998-04, Vol.38 (1), p.55-61

1998

Volltextzugriff (PDF)

0080: For Women Receiving Chemotherapy for Clinically Apparent Early Ovarian Cancer, is There a Benefit to Surgical Staging

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.623-623

2006

Volltextzugriff (PDF)

Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology

Journal of clinical oncology, 2015-03, Vol.33 (7), p.786-809

2015

Volltextzugriff (PDF)

Preterm labour and delivery: a genetic predisposition

Paediatric and perinatal epidemiology, 2001-07, Vol.15 (s2), p.57-62

Dizon-Townson, Donna S.

2001

Volltextzugriff (PDF)

Correlation between preoperative T1 breast cancer staging and final pathologic analysis

Journal of clinical oncology, 2011-09, Vol.29 (27_suppl), p.101-101

2011

Volltextzugriff (PDF)

Pegylated liposomal doxorubicin in recurrent serous carcinoma of the uterus

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e16538-e16538

2009

Volltextzugriff (PDF)

1 – 25 von 423

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(374)
Mit Volltextzugriff
(359)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Digitizing clinical trials

Phase I Trial of Bortezomib and Carboplatin in Recurrent Ovarian or Primary Peritoneal Cancer

Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancer

Management and outcomes for elderly women with vulvar cancer over time

A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852)

Reply to the letter to the editor ‘Integrating communication as a core skill in the global curriculum for medical oncology’ by Horlait et al

Retrospective Analysis of Carboplatin and Paclitaxel as Initial Second-Line Therapy for Recurrent Epithelial Ovarian Carcinoma: Application Toward a Dynamic Disease State Model of Ovarian Cancer

Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva

A phase II trial of combination nivolumab and bevacizumab in recurrent ovarian cancer

Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) study

Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of Müllerian origin

A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer

The factor V Leiden mutation may predispose women to severe preeclampsia

Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction

A Phase I Trial of the Novel Proteasome Inhibitor PS341 in Advanced Solid Tumor Malignancies

The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis

A promoter mutation that increases transcription of the tumor necrosis factor-α gene is not associated with preterm delivery

Importance of clarifying patients' desired role in shared decision making to match their level of engagement with their preferences

The sexuality clinic in the breast center: sex as a survivorship issue

A promoter mutation in the tumor necrosis factor α gene is not associated with preeclampsia

0080: For Women Receiving Chemotherapy for Clinically Apparent Early Ovarian Cancer, is There a Benefit to Surgical Staging

Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology

Preterm labour and delivery: a genetic predisposition

Correlation between preoperative T1 breast cancer staging and final pathologic analysis

Pegylated liposomal doxorubicin in recurrent serous carcinoma of the uterus

Suchergebnisse filtern